Related Experiment Videos
Antipyrine clearance in pneumonia
Clinical Pharmacology and Therapeutics
|June 1, 1985
Summary
Antipyrine clearance, a measure of liver drug metabolism, is reduced in patients with pneumonia. This impairment improves during recovery, indicating that acute illness affects the body's ability to process medications.
Area of Science:
- Pharmacology
- Hepatology
- Infectious Diseases
Background:
- Microsomal hepatic drug metabolism is crucial for drug detoxification.
- Pneumonia, an acute respiratory infection, can impact systemic physiological functions.
- Understanding drug metabolism during acute illness is vital for patient management.
Purpose of the Study:
- To investigate the impact of acute pneumonia on antipyrine clearance in adult patients.
- To assess the recovery of hepatic drug metabolism following resolution of pneumonia.
Main Methods:
- Antipyrine clearance was measured using a one-sample technique.
- The study included 14 adult patients diagnosed with acute fever and clinical pneumonia.
- Measurements were taken during the acute phase and during convalescence (14 and 28 days later).
Main Results:
- Mean antipyrine clearance during acute pneumonia was significantly reduced (31.4 +/- 7.6 ml/min).
- Clearance values increased substantially during convalescence (47.8 +/- 18.9 ml/min at 14 days and 49.2 +/- 15.0 ml/min at 28 days).
- The data indicate a temporary impairment of hepatic drug metabolism.
Conclusions:
- Pneumonia impairs microsomal hepatic drug metabolism in adults.
- Hepatic drug metabolism function recovers during the convalescent period after pneumonia.
- These findings highlight the systemic effects of pneumonia on drug processing.